New Risk • Jun 11
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: NT$3.12b (US$98.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Earnings have declined by 14% per year over the past 5 years. Minor Risks Revenue is less than US$5m (NT$82m revenue, or US$2.6m). Market cap is less than US$100m (NT$3.12b market cap, or US$98.7m). Reported Earnings • Apr 08
Full year 2025 earnings released: NT$0.84 loss per share (vs NT$0.74 loss in FY 2024) Full year 2025 results: NT$0.84 loss per share (further deteriorated from NT$0.74 loss in FY 2024). Revenue: NT$81.9m (up 7.2% from FY 2024). Net loss: NT$33.7m (loss widened 14% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 153% per year, which means it is well ahead of earnings. Aankondiging • Mar 20
Mortech Corporation, Annual General Meeting, Jun 23, 2026 Mortech Corporation, Annual General Meeting, Jun 23, 2026. Location: no,2-6, kung yeh 2nd rd., pingjhen district, taoyuan city Taiwan New Risk • Mar 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 20% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Revenue is less than US$5m (NT$93m revenue, or US$2.9m). Market cap is less than US$100m (NT$1.56b market cap, or US$49.6m). New Risk • Apr 07
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: NT$296.0m (US$8.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 23% per year over the past 5 years. Market cap is less than US$10m (NT$296.0m market cap, or US$8.95m). Minor Risk Revenue is less than US$5m (NT$76m revenue, or US$2.3m). Reported Earnings • Mar 30
Full year 2024 earnings released: NT$0.74 loss per share (vs NT$1.48 loss in FY 2023) Full year 2024 results: NT$0.74 loss per share (improved from NT$1.48 loss in FY 2023). Revenue: NT$76.4m (up 48% from FY 2023). Net loss: NT$29.6m (loss narrowed 50% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Aankondiging • Mar 21
Mortech Corporation, Annual General Meeting, Jun 23, 2025 Mortech Corporation, Annual General Meeting, Jun 23, 2025. Location: no,2-6, kung yeh 2nd rd., pingjhen district, taoyuan city Taiwan New Risk • Mar 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.3% average weekly change). Earnings have declined by 15% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Revenue is less than US$5m (NT$44m revenue, or US$1.4m). Market cap is less than US$100m (NT$410.0m market cap, or US$12.5m). New Risk • Feb 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Earnings have declined by 15% per year over the past 5 years. Minor Risks Revenue is less than US$5m (NT$44m revenue, or US$1.4m). Market cap is less than US$100m (NT$452.0m market cap, or US$13.8m). New Risk • Aug 18
New major risk - Revenue and earnings growth Earnings have declined by 15% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 15% per year over the past 5 years. Minor Risks Revenue is less than US$5m (NT$44m revenue, or US$1.4m). Market cap is less than US$100m (NT$552.0m market cap, or US$17.1m). Reported Earnings • Apr 03
Full year 2023 earnings released: NT$1.48 loss per share (vs NT$0.038 profit in FY 2022) Full year 2023 results: NT$1.48 loss per share (down from NT$0.038 profit in FY 2022). Revenue: NT$51.7m (down 54% from FY 2022). Net loss: NT$59.2m (down NT$60.7m from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 13% per year. Aankondiging • Mar 24
Mortech Corporation, Annual General Meeting, Jun 13, 2024 Mortech Corporation, Annual General Meeting, Jun 13, 2024. New Risk • Mar 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.4% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Revenue is less than US$5m (NT$102m revenue, or US$3.2m). Market cap is less than US$100m (NT$370.4m market cap, or US$11.7m). New Risk • Oct 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.8% average weekly change). Revenue is less than US$5m (NT$102m revenue, or US$3.2m). Market cap is less than US$100m (NT$396.0m market cap, or US$12.2m). Reported Earnings • Apr 21
Full year 2022 earnings released: EPS: NT$0.04 (vs NT$0.72 loss in FY 2021) Full year 2022 results: EPS: NT$0.04 (up from NT$0.72 loss in FY 2021). Revenue: NT$111.2m (flat on FY 2021). Net income: NT$1.53m (up NT$30.4m from FY 2021). Profit margin: 1.4% (up from net loss in FY 2021). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Reported Earnings • Mar 05
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: NT$0.72 loss per share (down from NT$0.45 loss in FY 2020). Revenue: NT$110.6m (up 29% from FY 2020). Net loss: NT$28.9m (loss widened 62% from FY 2020). Revenue was in line with analyst estimates. Reported Earnings • Aug 09
First half 2021 earnings released: NT$0.46 loss per share (vs NT$0.09 loss in 1H 2020) The company reported a soft first half result with increased losses and weaker control over costs, although revenues improved. First half 2021 results: Revenue: NT$55.1m (up 2.2% from 1H 2020). Net loss: NT$18.3m (loss widened 411% from 1H 2020). Reported Earnings • Apr 02
Full year 2020 earnings released: NT$0.45 loss per share (vs NT$0.50 loss in FY 2019) The company reported a soft full year result with weaker revenues and control over costs, although losses reduced. Full year 2020 results: Revenue: NT$85.7m (down 15% from FY 2019). Net loss: NT$17.9m (loss narrowed 4.9% from FY 2019). Is New 90 Day High Low • Jan 27
New 90-day low: NT$14.70 The company is down 17% from its price of NT$17.70 on 30 October 2020. The Taiwanese market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. Is New 90 Day High Low • Oct 29
New 90-day low: NT$17.30 The company is down 4.0% from its price of NT$18.00 on 31 July 2020. The Taiwanese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 4.0% over the same period.